Inflammatory disease of muscle
-
Upload
- -
Category
Health & Medicine
-
view
783 -
download
4
Transcript of Inflammatory disease of muscle
Inflammatory Diseases of MuscleInflammatory Diseases of Muscle
-- Polymyositis & Dermatomyositis-- Polymyositis & Dermatomyositis
魏正宗魏正宗
中山醫學大學附設醫院中山醫學大學附設醫院過敏免疫風濕科主任過敏免疫風濕科主任、、中藥臨床試驗中心主任中藥臨床試驗中心主任
Tel: 04 24729595 ext 34314; Email: [email protected]
醫學系「免疫與感染學醫學系「免疫與感染學 VV 」模組 」模組
學習目標
Inflammatory Diseases of MuscleInflammatory Diseases of Muscle DefinitionDefinition PathophysiologyPathophysiology Clinical manifestationsClinical manifestations DiagnosisDiagnosis TreatmentTreatment PrognosisPrognosis
Weakness, etiologies:Weakness, etiologies:
1.1. NerveNerve
2.2. Neuromuscular junctionNeuromuscular junction
3.3. MuscleMuscle
4.4. PsychogenicPsychogenic
5 subsets of inflammatory myopathies5 subsets of inflammatory myopathies
Proximal muscle weaknessProximal muscle weakness
Shoulders, thighs, trunk and pelvic girdle Shoulders, thighs, trunk and pelvic girdle muscles are most affected.muscles are most affected.
Never facial and ocular musclesNever facial and ocular muscles Esophagus, pharynx and respiratory Esophagus, pharynx and respiratory
muscles may involved.muscles may involved. May arthralgia and myalgiaMay arthralgia and myalgia
Heliotrope signHeliotrope sign
Heliotrope sign:Heliotrope sign:
皮肌炎 Dermatomyositis
V-sign: rash over anterior neck and upper chest
Gottron’s signGottron’s sign
Gottron’s signGottron’s sign
Gottron’s sign and periungual erythemaGottron’s sign and periungual erythema
Periungual erythemaPeriungual erythema
Vasodilatation in capillary microscope
Mechanist hand
Lab Lab
Muscle enzyme– Muscle enzyme– Creatine KinaseCreatine Kinase Indicator of disease activity and severityIndicator of disease activity and severity May be normal in very early, remission or May be normal in very early, remission or
atrophy pts. atrophy pts. CK rise weeks preceding clinical evidence of CK rise weeks preceding clinical evidence of
muscle weaknessmuscle weakness Other muscle enzymes: ALT, AST, LDH, Other muscle enzymes: ALT, AST, LDH,
aldolasealdolase
AutoantibodiesAutoantibodies ANA,ANA, anti-nuclear antibody ~80% anti-nuclear antibody ~80% Anti-ENA,Anti-ENA, extractable nuclear antigen extractable nuclear antigen
Anti-Jo-1Anti-Jo-1• most common myositis-specific autoantibody ~30%. most common myositis-specific autoantibody ~30%. • anti–anti–tRNA synthetasetRNA synthetase syndrome syndrome: Lung iinvolvement, Raynaud's : Lung iinvolvement, Raynaud's
phenomenonphenomenon Anti-SRP antibodiesAnti-SRP antibodies
• signal recognition particle (SRP) : translocation of newly signal recognition particle (SRP) : translocation of newly synthesized proteins into the endoplasmic reticulum. synthesized proteins into the endoplasmic reticulum.
• only in only in polymyositispolymyositis with with severesevere myopathy and aggressive myopathy and aggressive disease disease
Anti-Mi-2 antibodies Anti-Mi-2 antibodies • directed against a helicase involved in transcriptional activationdirected against a helicase involved in transcriptional activation• associated with the relatively acute onset of classic associated with the relatively acute onset of classic
dermatomyositisdermatomyositis with erythroderma and the shawl sign with erythroderma and the shawl sign
EMG of PM/DMEMG of PM/DM
• Triads in 40% of pts: polyphasic, small polyphasic, small amplitude, short amplitude, short durationduration
• Chracteristic but not Chracteristic but not diagnosticdiagnostic
• 15% of pts may be 15% of pts may be normal EMGnormal EMG
Muscle biopsy of polymyositisMuscle biopsy of polymyositis
•Focal and endomysial infiltration of T cell, esp. CD8, with small number of macrophage
•Muscle fiber degeneration and atrophy
Muscle biopsy of dermatomyositisMuscle biopsy of dermatomyositis
Peri-vascular Peri-vascular infiltration of infiltration of inflammatory cells, inflammatory cells, composed of composed of higher percentage higher percentage of of B cell and CD4B cell and CD4 T cells.T cells.
Image studyImage study
MRIMRI Muscle scanMuscle scan
Other systemic features of idiopathic Other systemic features of idiopathic inflammatory myopathyinflammatory myopathy
EsophagealEsophageal Uncoordinated peristalsisUncoordinated peristalsis RefluxReflux DysphagiaDysphagia
GastrointestinalGastrointestinal Uncoordinated peristalsisUncoordinated peristalsis Delayed gastric emptyingDelayed gastric emptying Ischemic necrosisIschemic necrosis
EndocrineEndocrine Autoimmune thyroiditisAutoimmune thyroiditis ““euthyroid sick “syndromeeuthyroid sick “syndrome
Cardiopulmonary featuresCardiopulmonary features
Cardiovascular Cardiovascular manifestationsmanifestations Raynaud’s Raynaud’s
phenomenonphenomenon MyocarditisMyocarditis Conduction Conduction
abnormalitiesabnormalities Heart failureHeart failure
Pulmonary Pulmonary manifestationmanifestation Diffuse interstitial Diffuse interstitial
diseasedisease Pulmonary hypertensionPulmonary hypertension Bronchiolitis obliterans Bronchiolitis obliterans
organizing pneumoniaorganizing pneumonia
Raynaud’s phenomenonRaynaud’s phenomenon
Diagnostic criteria of Diagnostic criteria of Dermatomyositis/PolymyositisDermatomyositis/Polymyositis
1.1. Proximal muscle weaknessProximal muscle weakness
2.2. Increased muscle enzyme(CK)Increased muscle enzyme(CK)
3.3. EMG findingsEMG findings
4.4. Muscle biopsyMuscle biopsy
5.5. Skin lesion Skin lesion -- Gottron's sign, heliotrope sign-- Gottron's sign, heliotrope sign
Myositis in autoimmune diseasesMyositis in autoimmune diseases
Common in scleroderma, SLE, MCTD, Common in scleroderma, SLE, MCTD, Sjogren’s syndromeSjogren’s syndrome
Sometimes in RA, Adult Still’s disease, Sometimes in RA, Adult Still’s disease, Vasculitis syndrome. Esp. Wegner’s Vasculitis syndrome. Esp. Wegner’s granulomatosis and polyarteritis nodosa.granulomatosis and polyarteritis nodosa.
Myositis association with malignancyMyositis association with malignancy
Frequency of malignancy in myositis Frequency of malignancy in myositis derived fromderived from 5% 5%-35%-35%
Most common sites: NPC, Lung, GI, GynMost common sites: NPC, Lung, GI, Gyn Work-up: careful Work-up: careful historyhistory and and PEPE and and
routine laboratoryroutine laboratory, tumor markers, image , tumor markers, image studiesstudies
Approaching DM/PM
Management of PM/DMManagement of PM/DM
Corticosteroid alone (60-100 mg/day)Corticosteroid alone (60-100 mg/day) Immunosuppressive agents in Immunosuppressive agents in
conjunction with corticosteroid conjunction with corticosteroid therapytherapy Hydroxychloroquine (100-200 mg/day)Hydroxychloroquine (100-200 mg/day) AzathioprineAzathioprine (2 mg/kg/d-50 mg/d) (2 mg/kg/d-50 mg/d) MethotrexateMethotrexate (MTX 7.5-25 mg/wk) (MTX 7.5-25 mg/wk) Cyclphosphamide (50-200mg/d)Cyclphosphamide (50-200mg/d) Cyclosporin ACyclosporin A (7.5-10mg/kg/d) (7.5-10mg/kg/d)
Steroid in MyositisSteroid in Myositis
prednisolone1-2 mg/kg/day or prednisolone1-2 mg/kg/day or methylprednisolone pulse therapymethylprednisolone pulse therapy
90% 90% improved after steroid therapy in improved after steroid therapy in weeks to monthsweeks to months
50-75% had complete remission50-75% had complete remission Need slowly tapering of steroidNeed slowly tapering of steroid Tends to occur when taper steroidTends to occur when taper steroid
Resistant diseaseResistant disease
- Rituximab (anti-CD20)- Rituximab (anti-CD20) - Intravenous immune globulin (IVIG) - Intravenous immune globulin (IVIG)
- Mycophenolate mofetil- Mycophenolate mofetil
- Tumor necrosis factor inhibitors - Tumor necrosis factor inhibitors
Unfavorable OutcomeUnfavorable Outcome
MalignancyMalignancy Other collagen vascular diseaseOther collagen vascular disease Raynaud’s phenomenonRaynaud’s phenomenon DysphagiaDysphagia Older ageOlder age Severe or refractory muscle diseaseSevere or refractory muscle disease Cardiac involvementCardiac involvement Pneumonitis/Interstitial lung diseasePneumonitis/Interstitial lung disease
ConclusionsConclusions
Workup of muscle weaknessWorkup of muscle weakness Differential diagnosis of myopathyDifferential diagnosis of myopathy Classification and diagnostic criteria of Classification and diagnostic criteria of
dermatomyositis and polymyositisdermatomyositis and polymyositis Has specific autoantibodiesHas specific autoantibodies Can be controlled by steroid and steroid-Can be controlled by steroid and steroid-
sparing agentssparing agents
ReferencesReferences
eMedicine : Polymyositis/Dermatomyositis eMedicine : Polymyositis/Dermatomyositis http://www.emedicine.com/neuro/topic85.htm
UpToDate UpToDate : Polymyositis/Dermatomyositis : Polymyositis/Dermatomyositis http://www.lib.csmu.edu.tw/overlib/2305.php